RU2012152206A - METHOD FOR DETERMINING EFFECTIVENESS OF ANTI-PANCREATIC THERAPY - Google Patents
METHOD FOR DETERMINING EFFECTIVENESS OF ANTI-PANCREATIC THERAPY Download PDFInfo
- Publication number
- RU2012152206A RU2012152206A RU2012152206/15A RU2012152206A RU2012152206A RU 2012152206 A RU2012152206 A RU 2012152206A RU 2012152206/15 A RU2012152206/15 A RU 2012152206/15A RU 2012152206 A RU2012152206 A RU 2012152206A RU 2012152206 A RU2012152206 A RU 2012152206A
- Authority
- RU
- Russia
- Prior art keywords
- pain
- dip
- points
- patient
- rest
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способ определения эффективности проводимой противопанкреатической терапии, включающий общеклиническое и физикальное обследование, биохимическое исследование крови больных, отличающийся тем, что в ходе лечения больного, каждые 24 часа определяют «динамический индекс панкреатита» (ДИП) по формуле:ДИП=(A/A)×(PS/PS)×(L/L)×(KБ/KБ), где: А, - значение амилазы крови пациента в настоящий момент; А- предыдущее значение амилазы крови; PS- среднее значение пульса пациента в настоящий момент; PS- предыдущее среднее значение пульса; L- количество лейкоцитов крови в настоящий момент; L- предыдущее количество лейкоцитов крови; KБ- «коэффициент боли» в настоящий момент; КБ- предыдущее значение «коэффициента боли»: КБ - «коэффициент боли», степень выраженности болевого синдрома, который оценивают в баллах: 0 баллов - боль в животе отсутствует в покое и при пальпации; 1 балл - имеется боль в животе при пальпации, отсутствует в покое; 2 балла - имеется боль в животе в покое, усиливается при пальпации; 3 балла - наряду с болевым синдромом, имеются положительные перитонеальные симптомы; и при ДИП<1 делают вывод о том, что проводимая противопанкреатическая терапия эффективна и достаточна, а при ДИП≥1 данное лечение неэффективно и нуждается в коррекции.A method for determining the effectiveness of ongoing anti-pancreatic therapy, including general clinical and physical examination, a biochemical blood test of patients, characterized in that during the treatment of the patient, every 24 hours, determine the "dynamic pancreatitis index" (DIP) by the formula: DIP = (A / A) × (PS / PS) × (L / L) × (KB / KB), where: A, is the patient’s blood amylase value at the moment; A - the previous value of blood amylase; PS - the average value of the patient’s pulse at the moment; PS - previous average heart rate; L is the current white blood cell count; L is the previous number of white blood cells; KB - "pain ratio" at the moment; CB - the previous value of the "pain coefficient": CB - "pain coefficient", the severity of pain, which is evaluated in points: 0 points - abdominal pain is absent at rest and on palpation; 1 point - there is abdominal pain during palpation, absent at rest; 2 points - there is abdominal pain at rest, aggravated by palpation; 3 points - along with pain, there are positive peritoneal symptoms; and with DIP <1, they conclude that the ongoing anti-pancreatic therapy is effective and sufficient, and with DIP≥1 this treatment is ineffective and needs to be corrected.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012152206/15A RU2520658C1 (en) | 2012-12-04 | 2012-12-04 | Method for determining effectiveness of administered anti-pancreatic therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012152206/15A RU2520658C1 (en) | 2012-12-04 | 2012-12-04 | Method for determining effectiveness of administered anti-pancreatic therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2012152206A true RU2012152206A (en) | 2014-06-10 |
RU2520658C1 RU2520658C1 (en) | 2014-06-27 |
Family
ID=51214190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012152206/15A RU2520658C1 (en) | 2012-12-04 | 2012-12-04 | Method for determining effectiveness of administered anti-pancreatic therapy |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2520658C1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2123703C1 (en) * | 1997-06-23 | 1998-12-20 | Наталья Борисовна Губергриц | Method of predicting development of persistent recurrent pancreatitis |
RU2403571C1 (en) * | 2009-06-08 | 2010-11-10 | Эдуард Володяевич Микаелян | Method of diagnosing inflammatory process course dynamics in case of pancreatitis in pre- and in post operational periods |
-
2012
- 2012-12-04 RU RU2012152206/15A patent/RU2520658C1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2520658C1 (en) | 2014-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX354371B (en) | Dosage regimen for administering a cd19xcd3 bispecific antibody to patients at risk for potential adverse effects. | |
EA201390530A1 (en) | METHOD OF OBTAINING CO-POLYMERA SODIUM CARBOXYMETHYL CELLULOSE AND GOSSIPOL AND ITS APPLICATION IN COMPLEX THERAPY OF PATIENTS WITH AUTHISTIC DISORDERS AND COGNITIVE DISORDERS | |
Franzén | Interventions for urinary incontinence in women | |
RU2012152206A (en) | METHOD FOR DETERMINING EFFECTIVENESS OF ANTI-PANCREATIC THERAPY | |
RU2013156363A (en) | DIAGNOSIS OF INFECTIOUS RESPIRATORY DISEASES USING BLOOD SAMPLES | |
RU2011147335A (en) | METHOD FOR ESTIMATING CLINICAL EFFICIENCY OF ANTI-AGREGANT THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME | |
RU2010122952A (en) | METHOD FOR DETERMINING THE STABILITY OF SMALL LABORATORY ANIMALS TO CIRCULATED HYPOXIA | |
EA201001297A1 (en) | METHOD FOR DIAGNOSTICS OF HUMAN MELANOMA ON THE BASIS OF DETERMINING THE EXPRESSION LEVEL PHF10 GENE, DIAGNOSTIC KIT | |
RU2010143284A (en) | METHOD FOR BEHAVIORAL PSYCHOTHERAPY OF PATIENTS WITH A LOW OR MIDDLE LEVEL OF PSYCHOTISM AT THE DENTAL RECEPTION | |
RU2012154164A (en) | METHOD FOR FORECASTING MEDICAL-SOCIAL EFFICIENCY OF COMPLEX TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION | |
RU2011116505A (en) | METHOD FOR DIAGNOSTIC OF VARIOUS FORMS OF ACUTE PYELONEPHRITIS | |
Orlova et al. | FRI0238 The level of leptin in patients with gout and its association with the gout activity score | |
Pavlovic et al. | Transient elastography in assessment of liver fibrosis in children with chronic hepatitis B: PEG-B-ACTIVE liver elasticity substudy | |
Awokola et al. | PS 08-25 PREVALENCE AND PREDICTORS OF FALLS AMONG ELDERLY HYPERTENSIVES IN SOUTH-SOUTH NIGERIA | |
RU132784U1 (en) | BOXING FOR SUPPORT METRIC PLATES | |
ALMOZNINO et al. | Sleep Quality in Patients with Temporomandibular Disorders (TMD) | |
Zamecnik et al. | Idiopathic inflammatory myopathies–increased expression of heat shock protein-90 in muscle tissue and plasma correlates with disease activity and skeletal muscle involvement | |
Rigolet et al. | Differential type I and type II interferon signatures in primary inflammatory/dysimmune myopathies | |
TSUBOI et al. | Histochemical Examination on the Effects of Alendronate on Osteocytic Lacunar-Canalicular-System | |
RU2013158791A (en) | METHOD FOR DIAGNOSTIC OF OCCUPATIONAL VASCULAR DISEASES IN PATIENTS WITH CARDIOVASCULAR DISEASES | |
Sutarli et al. | PS 08-27 HYPERTENSION AFFECTS PHYSICAL PERFORMANCE IN ELDERY | |
Baramzina | Chronic HCV-infection in the Kirov region: Dynamics of indices of disease in adults in 1995-2010 | |
RU2012114053A (en) | METHOD FOR DIAGNOSIS OF PURULENT TISSUE TREATMENT AND PREVALENCE OF THE PROCESS IN INFLAMMATORY DISEASES OF ABDOMINAL BODIES | |
Fokin et al. | SUBJECTIVE EVALUATION OF INDIVIDUAL GLAUCOMA SIGNIFICANCE | |
RU2491017C1 (en) | Method of predicting efficiency of correcting psychic component of person's life quality under emotional and stress load |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20141205 |